ReviewFrontiers in neuroscience2026
Acupuncture modulates the microbiota-gut-brain axis to treat irritable bowel syndrome: a mechanistic exploration.
Review in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder involving dysregulation of the microbiota-gut-brain (MGB) axis. Acupuncture effectively alleviates IBS symptoms, yet its underlying mechanisms remain incompletely understood. This review synthesizes current evidence to propose a mechanistic framework by which acupuncture treats IBS through MGB axis modulation. We systematically examine: (1) MGB axis dysfunction in IBS pathophysiology across neural, endocrine, and immune pathways; (2) acupuncture's modulation of gut microbiota structure (alpha/beta diversity, specific bacterial genera); (3) functional consequences including enhanced short-chain fatty acid production and tryptophan metabolism; (4) causal evidence from fecal microbiota transplantation; (5) correlations between microbiota changes and clinical improvement. Key findings reveal that acupuncture induces "convergent remodeling" of microbial structure toward a healthy profile, exerts "bidirectional regulation" on beneficial and harmful bacteria, and establishes a "niche selection" mechanism via neuro-immune pathways. These microbiota-mediated effects integrate with neural, endocrine, and immune pathways, forming a "point-to-surface" networked regulatory pattern that explains acupuncture's dual efficacy in alleviating both gastrointestinal and psychological symptoms. This review provides a novel theoretical framework for understanding acupuncture's therapeutic mechanisms and supports its clinical application in IBS management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.